Navigation Links
Biological Link Between BRCA1 and Breast Cancer Detailed
Date:1/17/2008

Finding suggests the gene, when not mutated, helps repair damaged DNA

THURSDAY, Jan. 17 (HealthDay News) -- A newly discovered role played by the breast cancer gene BRCA1 in repairing damaged DNA may help explain why women who inherit a mutated version of the gene are more likely to develop breast and ovarian cancer.

The finding, reported by Duke University Medical Center researchers, could also lead to more effective treatments for women with and without mutated versions of the gene, according the report in the Jan. 16 online edition of PLoS One.

"Since it was discovered in 1994, BRCA1 and its role in preventing and causing cancer has been intensely studied, and our research represents an important piece of the puzzle," lead investigator Craig Bennett, a researcher in Duke's Department of Surgery, said in a prepared statement.

"This study has identified an important mechanism by which BRCA1 comes into play when DNA -- the basis for all cell function -- is damaged. We have shown that this theory holds up not just in scientific models but in human breast cancer cells as well," Bennett said.

The BRCA1 pathway identified by the researchers "is directly involved with the critical process of transcription, in which RNA acts as a messenger between DNA and the making of proteins."

"We found that BRCA1 acts together with transcription to detect DNA damage and to signal the cell to repair itself. When BRCA1 does not function correctly, as when it is mutated, DNA damage remains un-repaired and cancer can occur," Bennett said.

The finding was first made in yeast and then duplicated in human breast cancer cells.

Women with a BRCA1 mutation are up to 80 percent more likely to develop breast cancer than other women, and are also more likely to develop the disease at a much younger age.

More information

The U.S. National Cancer Institute has more about

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Thomson Scientific Announces BONDplus for Biological Researchers
2. Neurobiological Technologies Reports Going Concern Qualification
3. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
4. Study questions assumptions about human sensitivity to biological motion
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
7. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
8. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
9. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
10. Comparison of obstetric outcomes between on-call and patients own obstetricians
11. Mailman School of Public Health study examines link between racial discrimination and substance use

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... care increases with longer doctor visits, researc...ews) -- Family doctors are now taking more time co...en and improving the quality of visits, a new stud...eir primary care physicians during office visits i...overall they seemed to receive better care," said ...
(Date:11/9/2009)... Course, to be Offered in April 201...it , Cambridge, MA (Vocus...cians for Human Rights (PHR) first inspected a sus... , he realized he would need a team of experts to ... the site properly was a key first step in securin...
(Date:11/9/2009)...NON, Tenn., Nov. 9 Health Connect ...ed it will host their inaugural Hospital O.R. and ...t the Marriott Renaissance Hotel in Nashville, Ten... than 100 hospital operating room directors and ma...th systems in the country. Some of the confirmed p...
(Date:11/9/2009)...YORK, Nov. 9 The award-w...s world television debut on the Sundance Channel o...T/PST. ,, Directed by Academy Award® nomi...of children with type 1 diabetes amid the verdant ...orld,s poorest countries. The children are support...
(Date:11/9/2009)...INGTON, Nov. 9 Speaker...ising provisions in the Affordable Health Care for...ess to Medicaid and reduce Medicare Part D costs f...he House on Saturday by a vote of 220 to 215: ,...ealth and quality of life for thousands of America...
Breaking Medicine News(10 mins):Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2
...salt a quick fix without losing taste, experts say... You can eat healthier this holiday season by alte...erts with the Texas AgriLife Extension Service. ,...ary Bielamowicz said in a news release. , "If a r...
...pies for preterm labor , , FRIDAY, Nov. 21... the switch that activates the uterine muscles for... lead to therapies for preterm labor. , The molec... researchers from Dartmouth Medical School in New ...
...niversity of Texas Health Science Center at Housto...n Aging Studies (TEXAS), to promote geriatrics tra...ion award from the Donald W. Reynolds Foundation a...acticing physicians. With the reach of Lyndon B. J...
...Generic,Pharmaceutical Association (GPhA) released... and CEO Kathleen Jaeger regarding the Federal Tra... Care Competition and Consumer Issues." , "T...dable biogenerics sooner rather than later. As ou...
...sity of Texas M. D. Anderson Cancer Center marked...ate breast cancer in Panama through the Partnershi...Americas today at an event with Laura Bush, the Fi....S. Department of State and Susan G. Komen for the...
... News & World Report and the National Committe...) HealthPlan of South Carolina in the top third of.... News & World Report,s issue this week. , ...QA and U.S. News & World Report ranked about 2...
Other Medicine News:Health News:Substitutions Make Holiday Fare Healthier 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
(Date:11/9/2009)...wswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (N... from the Company,s Bepreve(TM) (bepotastine besil...dies. These results were presented in poster sess...llege of Allergy, Asthma & Immunology (ACAAI) ...n titled, "Treatment of Ocular Itching with Bepota...
(Date:11/9/2009).... 9 Decision Resources, one of the...harmaceutical and healthcare issues, finds that, i...HER2) targeting therapies -- which include Roche/C...u,s Tykerb/Tyverb -- were the highest-selling drug...e of Herceptin and Tykerb/Tyverb and the expected ...
(Date:11/9/2009)...9 Shire plc (LSE: SH...aceutical company, today announced the availabilit... Tablets in pharmacies across the United States fo... Disorder ( ADHD ) in children and adolescents a... guanfacine, is the first and only nonscheduled al...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7Study shows how to boost value of Alzheimers fighting compounds 54660 1Study shows how to boost value of Alzheimers fighting compounds 54660 2Researcher says microchannels could advance tissue engineering methods 9601 1Researcher says microchannels could advance tissue engineering methods 9601 2Researcher says microchannels could advance tissue engineering methods 9601 3Researcher says microchannels could advance tissue engineering methods 9601 4Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 1Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 2Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 3Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 4
... Pivotal Trial Presented at Annual Meeting of ...ry --, SAN FRANCISCO and ORLANDO, Fla., March 15 ... that clinical results from,its first pivotal tria...ere,stabilized in patients with mild-to-moderate A...sulting in decreased caregiver distress. Benefits ...
...errimack Pharmaceuticals,Inc. today announced that...of 100 patients that evaluates the safety and effi...ring from rheumatoid arthritis (RA). MM-093 is a,r...)., The randomized, double-blind, placebo-control...s throughout the United States. The objective,of t...
Other Medicine Technology:Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 2Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 3Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 4Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis 2
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: